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Abstract
Background: Conventional Percutaneous Lithotripsy (PCNL) has been an effective, successful and easy approach for
especially > 1 cm sized calyceal stones however risks of complications and nephron loss are inevitable. Our aim is to
compare the efficacy and safety of PCNL, MiniPerc (MP) and UltraMiniPerc (UMP) for lower calyceal stones between
1 and 2 cm with a multicenter prospective randomized study.
Methods: Between January 2015 and June 2018, 132 consecutive patients with single lower calyceal stone were
enrolled. Patients were randomized in three groups; A: PCNL; B: MP; C: UMP. 44 patients for the Group A, 47 for
Group B and 41 for Group C. Exclusion criterias were the presence of coagulation impairments, age of < 18 or > 75,
presence of infection or serious comorbidities. Patients were controlled with computerized tomography scan after
3 months. A negative CT or an asymptomatic patient with stone fragments < 3 mm size were the criteria to assess
the stone-free status. Patient characteristics, stone free rates (SFR) s, complications and re-treatment rates were
analyzed.
Results: The mean stone size were 16.38, 16.82 and 15.23 mm respectively in Group A, B and C(p = 0.34). The
overall SFR was significantly higher in Group A (86.3%) and B (82.9%) as compared to Group C (78%)(p < 0.05). The
re-treatment rate was significantly higher in Group C (12.1%) and complication rates was higher in Group A (13.6%)
as compared to others(p < 0.05). The hospitalization was significantly shorter in Group C compared to Group A (p = 0.04).
Conclusions: PCNL and MP showed higher efficacy than UMP to obtain a better SFR. Auxiliary and re-treatment rates
were higher in UMP. On the other hand for such this kind of stones PCNL had more complications. Overall evaluation
favors MP as a better indication in stones 1–2 cm size.
Keywords: PCNL, Percutaneous, Miniperc, Ultraminiperc, Lower calyces stones , Stone-free rate
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: drbatu@hotmail.com
2Department of Urology, University of Modena and Reggio Emilia, Modena,
Italy
Full list of author information is available at the end of the article
Bozzini et al. BMC Urology           (2020) 20:67 
https://doi.org/10.1186/s12894-020-00636-z
Background
Lower calyceal (LC) stones approximately account for
35% of all renal stones [1]. Natural history of non-
obstructing asymptomatic LC stone is not well defined,
and the risk of progression is unclear. Although the ques-
tion of whether calyceal stones should be treated is still
unanswered and patients electing expectant management
should be counseled regarding the potential for stone-
related symptom progression and need for future inter-
vention [2]. Stone growth, de novo obstruction, associated
infection, stone composition, and acute and/or chronic
pain are general indications for treatment decision. Ac-
cording to the European Association of Urology (EAU)
guidelines as considered for LC stones, in case of unfavor-
able conditions for extracorporeal shockvawe lithotripsy
(ESWL), endourological interventions such as Percutan-
eous Nephrolithotomy (PCNL) or Retrograde Intrarenal
Surgery (RIRS) are recommended at first step [3].
LC stones have been a problem for both patients and
urologists. Due to the anatomical variations of LC, espe-
cially considering for stone clearance, ESWL has been
usually failed in here. Flexible ureterorenoscopic interven-
tions have also gained popularity by time for especially
endoscopic treatment of < 2 cm sized LC stones [3, 4]. But
again because of some anatomical difficulties and durabil-
ity of instrument it may not always be easy to perform
RIRS for all LC stones [5]. Conventional PCNL has been
an effective, successful and easy approach for LC stones
however risks of complications and nephron loss are inev-
itable [2]. But regarded to the invasiveness and morbidities
of PCNL, the optimal management of LC stones continue
to be a dilemma that has recently received heightened at-
tention among urologists. Moreover with time the
miniaturization of PCNL also developed in order to di-
minish access related complications, bleeding and morbid-
ities [6]. Conventionally the miniaturization of PCNL has
defined by diameter less than 20 Fr [7]. The Minipercuta-
neous (MP)(16–18 Fr), Ultraminiperc (UMP)(11–14 Fr)
and Micropercutaneous (MicroPNL) (< 10Fr) are cur-
rently feasible and modern alternatives with minimal inva-
siveness [2]. The MP is accepted as suitable for renal
stones < 2 cm in size while UMP is for renal stones < 1.5
cm [7, 8]. A prospective multicenter randomized compari-
son among PCNL, MP and UMP for LC stones between 1
and 2 cm according to CT scan was performed to evaluate
the efficacy and the safety of these procedures.
Methods
Between January 2015 and June 2018, 132 consecutive
patients presented with a singular 1–2 cm LC stone were
enrolled in this prospective, comparative, multicenter
and randomised study. The ethical committee approval
was taken in 2014 thus gave the possibility to start at the
same time in January 2015 for each participating center.
Randomized number table was used for simple
randomization. Patients were randomized into three
groups; Group A: patients treated with PCNL; Group B:
patients treated with MP; Group C: patients treated with
UMP. The Hounsfield Unit (HU) of each group was
1234 ± 256, 1113 ± 341 and 1254 ± 289 for Group A, B
and C respectively. The main inclusion criteria was re-
lated on stone’s maximum diameter in coronal images
on CT scans. Exclusion criteria were the presence of co-
agulation impairments, age less than 18 or more than 75
(with increased risks of elongated procedure under gen-
eral anesthesia leading with incomplete completion of
interventions), presence of acute infection, presence of
cardiovascular or pulmonary comorbidities. 8 patients
for Group A, 9 for Group B and 7 for Group C were ex-
cluded. Patients were controlled with CT scan after 3
months. A negative CT or an asymptomatic patient with
< 3 mm residual stone fragments and a negative urinary
culture were the criteria to obtain the stone-free status
(SFR). We accepted stone-free status as inferior to 3 mm
and at least if the fragments we more than 2 in number
with a residual area less than 9mm2. A numerical pain
scale from 0 to 10 was used for evaluation and compari-
son of pain levels. A statistical analysis was carried out
to assess patients data, success and complications rates,
re-treatment rate and need for auxiliary treatment. The
informed written consent has been obtained from each
participant, that study has been performed according to
the Declaration of Helsinki, and the procedures have
been approved by local ethics committee.
PCNL, MP and UMP procedures
All PCNL procedures were started with the ureteral
catheterization of stone side via cystoscopy. Under the
semi-flex supine positioning access to kidney was per-
formed by combined guidance of intraoperative ultra-
sonography (US) and fluoroscopy. After a successfully
co-axial dilatation on guidewire up to a 30 CH Amplatz
sheath, 800 μm Laser fiber with Litho 35W (Quanta Sys-
tem, Samarate, Lombardia VA) was used for stone frag-
mentation (0.6–0.8 J 12 Hz) through a 24 Fr
nephroscope (Karl-Storz) whereas retrieval grasper for
stone extraction. A standart re-entry nephrostomy cath-
eter was placed at the end and left for two days
postoperatively.
The initial procedures before access, as cystoscopy and
ureteral catheterization were similarly helded also in MP
and UMP as during in PCNL. During MP, a 16 Fr
nephroscope (Karl-Storz) was used with a smaller sheath
size of 16.5/19.5 Fr (Karl-Storz) as compared to conven-
tional PCNL. 550 μm Laser fiber with Cyber Ho was
used by the help of a delicate forceps and nitinol basket
for clearance of fragments. So at the end a small 10 Fr
diameter nephrostomy catheter was placed.
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Different than the two techniques, during UMP a gen-
tle single step dilatation was needed for UMP sheath
11–13 Fr and Holmium laser energy was used through a
6 Fr nephroscope (Karl-Storz) for stone fragmentation.
Again similar to MP, 550 μm Laser fiber with Cyber Ho
was used. Neither graspers nor basket were used. Saline
irrigation was mainly used to remove the stone frag-
ments. Differently than other procedures, nephrostomy
tube was not used.
For the all groups papilla access technique was used.
The conventional PCNL could be used with balistic and
ultrasonic lithotriptors as well but we used the laser frag-
mentation modality in order not to have bias regarding in
between all three interventions. The energy settings did
not differ in between procedures. Fragmentation method
was used during PCNL whereas dusting method was used
during MP and UMP. All the surgeons who had per-
formed the procedures were all completed their learning
curve on three techniques prior to this study with a mini-
mum case record of 250 procedures for each technique.
All the three procedures were done in two centers with
six experienced surgeons.
Statistical analyses
The Shapiro-Wilk normality test was used to evaluate
the behavior of the continuous variables. The collected
data were analysed by an online regression tool (Stu-
dent’s t-test and chi-square test). The calculation of the
sample size was done using “Creative Research System
Software” indicating 95% as confidence level and a confi-
dence interval (margin of error) of 15%. A post-hoc re-
gression analysis was also performed on 3rd months
SFR. For all statistical comparisons, significance was
considered at p < 0.05.
Results
Group A was consisted of 44 patients while Group B
and Group C were consisted of 47 and 41 patients re-
spectively. The mean stone size was 16.38 mm in Group
A, 16.82 mm in Group B and 15.23 mm in Group C (p =
0.34). Our patient and stone related characteristics were
all statistically similar in between the groups (p > 0.05)
(Table 1). The overall SFR was 86.3% for Group A,
82.9% for Group B and 78.0% for Group C. The compli-
cation rates were 13.6, 4.2 and 2.4% respectively for
group A, B and C. The re-treatment rates were signifi-
cantly higher in group C compared to the other two
groups (p = 0.007). Our analyze was by intention to treat
so further on considering the re-treatment, RIRS was
performed to get a stone free situation. The operating
time did not show a significant difference in between the
groups. The hospitalization was significantly shorter in
Group C compared to Group A (p = 0.04) (Table 2). The
post-hoc regression analysis on 3rd month SFR for
groups was shown in Table 3. The complications of all
groups were assessed and summarized as based up on
clinical evidences (Table 4). The clinically evident com-
plications were significantly higher in Group A as com-
pared to the other groups (p < 0.05) (Table 4). The
distribution of post-operative complications according to
Clavien-Dindo was summarized in Table 5. The Clavien-
Dindo scale of scores were higher in Group A as com-
pared to the other groups (p < 0.05).
Discussion
The LC stones have always been problematic in order to
obtain a total stone clearance. It is very well discussed in
literature as a systematic review and meta-analysis
showed PCNL and RIRS were superior to ESWL in
stone clearance and even PCNL is more effective then
RIRS [9]. In 2017 Bozzini et al. performed a prospective
randomized comparison among ESWL, PCNL and RIRS
on < 2 cm sized LC stones [10]. ESWL was failed against
PCNL and RIRS considering SFR and re-treatment
rates(p < 0.05). The SFRs were significantly higher in
PCNL (87.3%) and RIRS (82.1%) as compared to ESWL
(61.8%). The duration of procedure and hospital stay, ra-
diation exposure favored RIRS against PCNL [10]. RIRS
looks a feasible and better option against PCNL when
complication rates were also taken in consideration. But
still RIRS may not be performed on all LC stones suc-
cessfully due to anatomic variations as narrow ureter or
calyceal infindibulum. So among with the miniaturized
PCNL modalities as MP, UMP and MicroPNL there
need of a decision to choice the priority for most effect-
ive and safe intervention against < 2 cm LC stones even
in case of narrow calyx existence [2].
The MP was first described and experienced with a
single step dilatation with usage of 11 Fr sheath on 11
cases at preschool age [11]. At the same year an initial
results from an adult study appeared [12]. Nine patients
with < 2 cm stones were treated with 13 Fr MP. 89%
stone-free rate was achieved while with better outcomes
Table 1 The demographic and stone related characteristics of
groups
Group A Group B Group C p value
Total patient (n = 132) 44 47 41 0.44
Age yrs
(mean ± SD)
53.3 ± 14.8 55.8 ± 16.1 54.8 ± 17.2 0.33
Sex (M/F) 23/21 20/27 22/19 0.23
Height cm (mean ± SD) 171.1 ± 2.5 175.8 ± 4.1 173.2 ± 2.3 0.40
Weight Kg (mean ± SD) 73.1 ± 4.6 77.9 ± 4.7 75.5 ± 7.1 0.66
Stone side (Right/Left) 25/19 22/25 21/20 0.52
Stone size (mm)
(mean ± SD)
16.38 ± 2.9 16.82 ± 2.7 15.23 ± 3.3 0.34
Group A: PCNL, Group B: MP, Group C: UMP
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in selected patients favoring MP for blood loss, hospital
stay and postoperative pain [12]. Despite this, Giusti
et al. declared that MP had no obvious advantage against
PCNL and concluded as tubeless PCNL could be a bet-
ter option [13]. But Knoll et al. defended that not all
tubeless PCNL procedures has ended with delighted re-
sults. Some cases need auxiliary interventions. Even be-
ing a limitation in their study that stone sizes were
smaller in MP patients; the results were comparable in
means of safety and effectiveness. More, the short hos-
pital stay, less pain and more possibility for tubeless
completion of operations has favored MP [14]. The MP
studies have showed comparable and equal SFR and re-
duced comorbidities compared to conventional PCNL
[8, 14, 15]. ElSheemy et al. compared MP and standard
PCNL through 18 and 30 Fr tracts respectively [16]. Ac-
cording to their results there was significant difference
on SFR in between patients who had larger stone burden
(>2cm2). But for those with singular stones or stone bur-
den ≤2 cm2; there was no significant difference in SFR
and also MP showed lower complications compared to
standard PCNL [16]. Similar to the current literature, in
our study there was no significant difference in between
SFR of PCNL and MP(p = 0.33) while a significant differ-
ence in between complication rates (p = 0.001) (Table 2).
In 2013, the UMP technique was published with initial
experiences in literature [17]. Desai et al. used a 6 Fr
mini nephroscope through a 11/13 Fr metal sheath on
36 consecutive patients with stone size of < 2 cm [17].
Similar to our access method, ultrasonographic guidance
was also used in addition to fluoroscopy. Not all stones
were located in LC. The LC stone ratio and LC access
ratio were 27.8 and 38.9% respectively while 8.3% of
their patients had multiple calyceal stones. Their imme-
diate (postoperative 1st day) and total (postoperative 1st
month) SFR’s were 88.9 and 97.2% respectively [17].
More, their significant complication (urosepsis, extrava-
sation and fever) ratio was 16.7% and need for a second
intervention was 2.8% whereas ours were 2.4 and 12.1%
respectively. This inverse ratio may be explained with
the differences between operative time, stone analysis,
surgeon experience or other patient characteristics in
between the studies.
In a cohort study of 98 consecutive UMP patients, the
mean stone size was 15.85 ± 4.53 mm which was com-
parable of ours (15.23 ± 3.3 mm) but their postoperative
SFR on 1st month control was 83% [18]. Jones et al.
published a systematic review study investigating the
role of MicroPNL and UMP. Across seven studies a total
of 262 patients were undergone UMP with a mean of
stone size 18.6 mm, SFR of 88.3% and complication rate
of 6.2% [19]. In our study, we calculated the SFR on 3rd
month control. The SFR of our UMP was calculated as
78% which was also significantly lower than our PCNL
and MP groups.
Ganpula et al. discussed well the differences between
PCNL, MP and UMP [7]. The cross-sectional area and
length differences of access sheats and more the smaller
fragments obtained during MP all create a superior frag-
ment vacuum clearance during MP compared to PCNL.
Also sheath sizes of MP may give a chance to use flex-
ible nephroscope for stone fragments in smaller different
calyces [7]. So these all may participate to the similar
SFR in between PCNL and MP. Again in another study,
during the interventions on 15–30 mm renal stones, 16.5
Fr MP showed comparable SFR but lower complications
as compared with 24 Fr PCNL [20]. According to a re-
cent review study the terminology seems to be confusing
in between the modalities but all miniaturized tract size
interventions result with better outcomes in terms of
pain and complication rates whereas comparable SFR
with standart PCNL [21]. Depending on our comparison
in between MP and UMP complication ratios were com-
parable but our SFR results in between MP and UMP
Table 2 The comparison of re-treatment needs, complications and SFRs percentages of groups
Group A Group B Group C p value
A-B
p value A-C p value B-C
Need for re-treatment (%) 6.8 4.2 12.1 0.17 0.41 0.007
Operating time min ± SD 45.9 ± 7.7 55.8 ± 11.4 59.3 ± 13.8 0.07 0.05 0.17
Hospitalization days ± SD 3.7 ± 1.5 2.7 ± 2.1 2.2 ± 2.1 0.06 0.04 0.18
Complication rate (%) 13.6 4.2 2.4 0.001 0.002 0.25
SFR at 3rd month (%) 86.3 82.9 78 0.33 0.022 0.02
Group A: PCNL, Group B: MP, Group C: UMP, SFR: Stone-free rate. Re-treatment (Secondary Interventions): Retrograde Intrarenal Surgery (RIRS)
Table 3 Post-hoc logistic regression analysis on 3rd month SFR
SFR at 3rd month
Group Log-odds Odds Probability
A 1.91 7.02 0.87
B 1.81 5.42 0.83
C 0.72 1.88 0.77
Group A: PCNL, Group B: MP, Group C: UMP, SFR: Stone-free rate
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were statistically significant(p = 0.02). According to our
results mean stone size were similar as 16.38 mm, 16.82
mm and 15.23 mm respectively. The UMP looks like an
alternative to MP but may not be satisfactory especially
for interventions on stones with > 1.5 cm sized. The
UMP may also be a good alternative to RIRS especially
for medium sized (< 1.5 cm) LC stones. This mismatch
between the ideal indication for UMP and the stone size
treated with UMP in this study may have meaningful
bias on the results and downgraded the potential efficacy
of UMP. However, currently due to the lack of literature
there are no clear guideline on MP and UMP.
The PCNL was at highest risk of complication co-
existence. The clinically evident complications in Table 4
were all higher in PCNL compared to MP and UMP. Only
among those, between PCNL and MP the severe pain
seems to be questionable(p = 0.05). According to Mishra
et al. the need of postoperative analgesics were similar be-
tween PCNL and MP [8]. More in contrast to PCNL, none
of the patients who were undergone MP and UMP proce-
dures needed a further surgical or endoscopic interven-
tions according to Clavien-Dindo classification [22] score
of >III (Table 5). Also there was no difference among clin-
ically evident complications between MP and UMP. Care-
ful selection of patients, experience of surgeon and special
equipment for each intervention is essential.
The number of the patients in each groups may be a
statistical limitation. So we can assume that surely the
tendency (obtained by univariate analysis) would be bet-
ter confirmed by randomized control trial with higher
numbers on which we are already working.
Here in our study a limitation may be lack of evalu-
ation according to the stone analysis or Hounsfield unit
(HU). We did not include pediatric age group (< 18) in
order not to increase the heterogeneity with extra choice
of MP and UMP. Moreover, exclusion of patients more
than 75 years old seems to be a potential selection bias
but but increased risks with older age under general
anesthesia may require incomplete termination of pro-
cedure which may also be a cause of bias on postopera-
tive outcomes.
Tubeless or non-tubeless comparison may be also con-
sidered in future studies. MP may seem to be supported
as first choice of PCNL subtype considering the 1–2 cm
sized LC stones. UMP may be recommended for certain
selected patients. Further studies with giant patient
groups may show comparable SFR in between MP and
UMP. As last, the use of the same Holmium laser energy
during the interventions might give the possibility to
focus only on the technique chosen and not a different
kind of energy to break the stone.
Conclusion
PCNL and MP showed higher efficacy than UMP in order
to obtain a better SFR. Auxiliary and re-treatment rates
were similar between PCNL and MP but differed in be-
tween MP and UMP. On the other hand for such this kind
of stones PCNL had more complications among all. The
MP and UMP find a better indication whereas MP seems
to be the preferential alternative for 1–2 cm LC stone
intervention among the others. Further randomized com-
parison between RIRS and MP in this setting is needed.
Table 4 The complications (Clinical evidences)
Group A (44) Group B (47) Group C (41) p value A-B p value A-C p value B-C Total
UTI n (%) 4 (9.2) 2 (4.2) 1 (2.4) 0,0320 0,0230 0,2300 7 (5.3)
Gross haematuria
n (%)
2 (4.5) 0 (0) 0 (0) 0,0020 0,0030 10,000 2 (1.5)
Severe pain n (%) 2 (4.5) 1 (2.1) 1 (2.4) 0,0500 0,0510 0,3475 4 (3.0)
Total n (%) 8 (18.2) 3 (6.3) 2 (4.8) 0,0410 0,0320 0,1300 13 (9.8)
Group A: PCNL, Group B: MP, Group C: UMP, UTI: Urinary tract infection
Table 5 The postoperative complications (Clavien-Dindo classification)





















0,0280 0,0190 0,0961 11 (8.3)
3a-5 n (%) 2 (4.5)
Gross Hematuria
0 (0) 0 (0) 0,0020 0,0030 10,000 2 (1.5)
Group A: PCNL, Group B: MP, Group C: UMP, UTI: Urinary tract infection
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